A detailed history of Cerity Partners LLC transactions in Geron Corp stock. As of the latest transaction made, Cerity Partners LLC holds 22,065 shares of GERN stock, worth $80,757. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,065
Holding current value
$80,757
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$4.17 - $4.99 $92,011 - $110,104
22,065 New
22,065 $100,000
Q1 2024

May 14, 2024

BUY
$1.75 - $3.44 $35,022 - $68,844
20,013 New
20,013 $66,000
Q4 2022

Feb 15, 2023

BUY
$2.03 - $2.42 $21,434 - $25,552
10,559 New
10,559 $25,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.38B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.